CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-04 | GREER R SCOTT Director | Sale | −1,400 | $61.99 | $87K | 130,333 |
| 2018-06-04 | GREER R SCOTT Director | Exercise or conversion · Stock Option | −1,400 | 28,600 | ||
| 2018-05-16 | Thomsen Jillian B. SVP & Chief Accounting Officer | Sale | −3,576 | $83.39 | $298K | 65,281 |
| 2018-05-16 | ROBIN HOWARD W President & CEO | Sale | −12,791 | $83.39 | $1.1M | 224,356 |
| 2018-05-16 | Nicholson John SVP & Chief Operating Officer | Sale | −4,917 | $83.39 | $410K | 162,596 |
| 2018-05-16 | Labrucherie Gil M SVP & Chief Financial Officer | Sale | −4,941 | $83.39 | $412K | 94,798 |
| 2018-05-16 | Hora Maninder SVP Pharma Dev & Mfg Ops | Sale | −4,060 | $83.39 | $339K | 76,201 |
| 2018-05-16 | Doberstein Stephen K SVP & Chief Scientific Officer | Sale | −3,435 | $83.39 | $286K | 63,959 |
| 2018-05-03 | CHESS ROBERT Director | Exercise or conversion | +10,000 | $14.26 | $143K | 284,223 |
| 2018-05-03 | CHESS ROBERT Director | Sale | −10,000 | $82.79 | $828K | 274,223 |
| 2018-05-03 | CHESS ROBERT Director | Exercise or conversion | +15,000 | $5.14 | $77K | 289,223 |
| 2018-05-03 | CHESS ROBERT Director | Sale | −15,000 | $82.81 | $1.2M | 274,223 |
| 2018-05-03 | CHESS ROBERT Director | Exercise or conversion · Stock Option | −10,000 | 10,000 | ||
| 2018-05-03 | CHESS ROBERT Director | Exercise or conversion · Stock Option | −15,000 | 0 | ||
| 2018-05-03 | Labrucherie Gil M SVP & Chief Financial Officer | Exercise or conversion | +30,000 | $10.69 | $321K | 129,739 |
| 2018-05-03 | Labrucherie Gil M SVP & Chief Financial Officer | Sale | −30,000 | $82.86 | $2.5M | 99,739 |
| 2018-05-03 | Labrucherie Gil M SVP & Chief Financial Officer | Exercise or conversion · Stock Option | −30,000 | 0 | ||
| 2018-05-03 | ROBIN HOWARD W President & CEO | Exercise or conversion | +43,333 | $10.69 | $463K | 280,480 |
| 2018-05-03 | ROBIN HOWARD W President & CEO | Sale | −43,333 | $82.86 | $3.6M | 237,147 |
| 2018-05-03 | ROBIN HOWARD W President & CEO | Exercise or conversion · Stock Option | −43,333 | 170,000 |
Page 32 of 43 · 847 trades